Unlock stock picks and a broker-level newsfeed that powers Wall Street.

MCE - Delayed Quote EUR

Grifols SA (GRF-P.MC)

6.35
-0.05
(-0.78%)
As of 1:40:31 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,212,382
7,212,382
6,591,977
6,063,967
4,933,118
Cost of Revenue
4,417,844
4,417,844
4,108,495
3,850,257
2,970,522
Gross Profit
2,794,538
2,794,538
2,483,482
2,213,710
1,962,596
Operating Expense
1,639,327
1,639,327
1,764,905
1,534,752
1,400,087
Operating Income
1,155,211
1,155,211
718,577
678,958
562,509
Net Non Operating Interest Income Expense
-701,124
-701,124
-559,447
-462,665
-256,151
Other Income Expense
-10,091
-10,091
47,891
121,720
44,095
Pretax Income
443,996
443,996
207,021
338,013
350,453
Tax Provision
231,190
231,190
43,349
90,111
85,126
Net Income Common Stockholders
156,920
156,920
42,318
185,035
188,726
Diluted NI Available to Com Stockholders
156,920
156,920
42,318
185,035
188,726
Basic EPS
0.23
0.23
0.06
0.27
0.27
Diluted EPS
0.23
0.23
0.06
0.27
0.27
Basic Average Shares
679,668.55
679,668.55
679,756.29
679,805.14
681,556.94
Diluted Average Shares
679,916.72
679,916.72
679,756.29
679,805.14
681,556.94
Total Operating Income as Reported
1,192,015
1,192,015
782,317
782,436
595,064
Total Expenses
6,057,171
6,057,171
5,873,400
5,385,009
4,370,609
Net Income from Continuing & Discontinued Operation
156,920
156,920
42,318
185,035
188,726
Normalized Income
192,091.25
192,091.25
54,119.37
170,569.23
205,113.54
Interest Income
44,423
44,423
62,430
33,859
11,551
Interest Expense
602,571
602,571
516,060
444,543
233,813
Net Interest Income
-701,124
-701,124
-559,447
-462,665
-256,151
EBIT
1,046,567
1,046,567
723,081
782,556
584,266
EBITDA
1,484,464
1,484,464
1,169,503
1,193,536
944,033
Reconciled Cost of Revenue
4,417,844
4,417,844
4,108,495
3,850,257
2,970,522
Reconciled Depreciation
437,897
437,897
446,422
410,980
359,767
Net Income from Continuing Operation Net Minority Interest
156,920
156,920
42,318
185,035
188,726
Total Unusual Items Excluding Goodwill
-46,895
-46,895
-14,927
19,724
-21,648
Total Unusual Items
-46,895
-46,895
-14,927
19,724
-21,648
Normalized EBITDA
1,531,359
1,531,359
1,184,430
1,173,812
965,681
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-11,723.75
-11,723.75
-3,125.63
5,258.23
-5,260.46
12/31/2021 - 6/3/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
 
AMGN.MX Amgen Inc.
5,500.00
0.00%
 
4AB.F AbbVie Inc.
155.80
+0.65%
 
OPHLY Ono Pharmaceutical Co., Ltd.
4.1500
+5.87%
 
ORNBVh.XC
 
PNVL3.SA Dimed S.A. Distribuidora de Medicamentos
8.71
-0.68%
 
NOV.MU Novo Nordisk A/S
54.09
-0.64%
 
0R34.IL Johnson & Johnson
155.78
-1.34%
 
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,916.75
+2.31%
 
NOTA.DU Novartis AG
97.60
+0.62%